OpenAlex
PricingAboutJobs
Log inGet started
Work

Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure

HTML

Year: 2009
Type: article
Study design: Clinical Trial
Source: European Journal of Cancer
DOI: 10.1016/j.ejca.2009.02.011
Authors: S. George, J.Y. Blay, P.G. Casali, A. Le Cesne, P. Stephenson, S.E. DePrimo, C.S. Harmon, C.N.J. Law, J.A. Morgan, I. Ray-Coquard, V. Tassell, D.P. Cohen, G.D. Demetri
Institutions: Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Lyon 1 Université, Centre Léon Bérard, Fondazione IRCCS Istituto Nazionale dei Tumori, Institut Gustave Roussy, Rho (United States), Pfizer (United States), Hospices Civils de Lyon
Language: English

Topic: Gastrointestinal Tumor Research and Treatment
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Keywords: sunitinib, gastrointestinal stromal tumor, imatinib resistance, continuous daily dosing, dosing regimen, pharmacokinetics, pharmacodynamics, antitumour activity, drug safety, progression-free survival, overall survival
SDG: Good health and well-being

Open Access status: closed

Funders: Pfizer, Institut Gustave-Roussy
OpenAlex ID: W1989535705
FWCI: 37.63
Cites: 24
Cited by: 397
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms